Evidence map›Paper›PMID 38816440›Full record

ArticleScientific reports2024

AmiA and AliA peptide ligands, found in Klebsiella pneumoniae, are imported into pneumococci and alter the transcriptome.

Janine Lux, Lucía Sánchez García, Patricia Chaparro Fernández, Laura Laloli, Manon F Licheri, Clement Gallay, Peter W M Hermans, Nicholas J Croucher, Jan-Willem Veening, Ronald Dijkman and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Janine LuxInstitute for Infectious Diseases, Faculty of Medicine, University of Bern, Friedbühlstrasse 25, CH-3001, Bern, Switzerland.
Lucía Sánchez GarcíaInstitute for Infectious Diseases, Faculty of Medicine, University of Bern, Friedbühlstrasse 25, CH-3001, Bern, Switzerland.
Patricia Chaparro FernándezInstitute for Infectious Diseases, Faculty of Medicine, University of Bern, Friedbühlstrasse 25, CH-3001, Bern, Switzerland.
Laura LaloliInstitute for Infectious Diseases, Faculty of Medicine, University of Bern, Friedbühlstrasse 25, CH-3001, Bern, Switzerland.
Manon F LicheriInstitute for Infectious Diseases, Faculty of Medicine, University of Bern, Friedbühlstrasse 25, CH-3001, Bern, Switzerland.
Clement GallayDepartment of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.
Peter W M HermansJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands.
Nicholas J CroucherMRC Centre for Global Infectious Disease Analysis, White City Campus, Imperial College London, Sir Michael Uren Hub, London, UK.
Jan-Willem VeeningDepartment of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.
Ronald DijkmanInstitute for Infectious Diseases, Faculty of Medicine, University of Bern, Friedbühlstrasse 25, CH-3001, Bern, Switzerland.
Daniel StraumeFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, 1430, Ås, Norway.
Lucy J HathawayInstitute for Infectious Diseases, Faculty of Medicine, University of Bern, Friedbühlstrasse 25, CH-3001, Bern, Switzerland. lucy.hathaway@unibe.ch.

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 192067
6 · The paper itself

Abstract

Klebsiella pneumoniae releases the peptides AKTIKITQTR and FNEMQPIVDRQ, which bind the pneumococcal proteins AmiA and AliA respectively, two substrate-binding proteins of the ABC transporter Ami-AliA/AliB oligopeptide permease. Exposure to these peptides alters pneumococcal phenotypes such as growth. Using a mutant in which a permease domain of the transporter was disrupted, by growth analysis and epifluorescence microscopy, we confirmed peptide uptake via the Ami permease and intracellular location in the pneumococcus. By RNA-sequencing we found that the peptides modulated expression of genes involved in metabolism, as pathways affected were mostly associated with energy or synthesis and transport of amino acids. Both peptides downregulated expression of genes involved in branched-chain amino acid metabolism and the Ami permease; and upregulated fatty acid biosynthesis genes but differed in their regulation of genes involved in purine and pyrimidine biosynthesis. The transcriptomic changes are consistent with growth suppression by peptide treatment. The peptides inhibited growth of pneumococcal isolates of serotypes 3, 8, 9N, 12F and 19A, currently prevalent in Switzerland, and caused no detectable toxic effect to primary human airway epithelial cells. We conclude that pneumococci take up K. pneumoniae peptides from the environment via binding and transport through the Ami permease. This changes gene expression resulting in altered phenotypes, particularly reduced growth.

Indexed as

Bacterial ProteinsGene Expression Regulation, BacterialKlebsiella pneumoniaeStreptococcus pneumoniaeTranscriptomeHumansLigandsMembrane Transport ProteinsPeptidesBacterial ProteinsLigandsMembrane Transport Proteinsoligopeptide permease, BacteriaPeptides

Identifiers

PMID38816440
PMCPMC11139975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.